1st. line treatment
Showing 1 - 25 of >10,000
Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer
Recruiting
- Lung Cancer Non-small Cell Stage IV
-
Athens, GreeceHellenic Cooperative Oncology Group
Nov 14, 2022
Among Advanced Renal Cell Carcinoma Receiving Systemic
Not yet recruiting
- Carcinoma, Renal Cell
- (no location specified)
Sep 6, 2022
es in OVArian Cancer HRD+ Status in Russian Federation
Recruiting
- Ovarian Cancer
-
Arkhangelsk, Russian Federation
- +18 more
Jun 26, 2023
Cardiology, Coronary Artery Disease Trial (Coronary CT in 1st line compared to the strategy with functional test in 1st line in
Not yet recruiting
- Cardiology
- Coronary Artery Disease
- Coronary CT in 1st line compared to the strategy with functional test in 1st line in patient at Intermediate Risk of Developing Stable Coronary Disease:
- (no location specified)
May 5, 2022
HIV-1-infection Trial in Moscow, Saint-Petersburg (VM-1500A-LAI, Standard of Care)
Not yet recruiting
- HIV-1-infection
- VM-1500A-LAI
- Standard of Care
-
Moscow, Russian Federation
- +1 more
Jan 21, 2022
Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)
Active, not recruiting
- Stomach Neoplasms
- +2 more
- Atezolizumab
- +3 more
-
Beijing, China
- +10 more
Dec 21, 2022
Durvalumab in Combination With Standard Chemotherapy of
Recruiting
- Small-cell Lung Cancer
- Extensive-stage Small-cell Lung Cancer
-
Néo Fáliro, GreeceMetropolitan Hospital
Mar 7, 2023
Real-world Prescription Pattern of Palbociclib Combination
Active, not recruiting
- Metastatic Breast Cancer
- Patients who received Palbociclib as first line therapy in MBC setting
-
Seoul, Korea, Republic ofPfizer Local Country Office
Jun 28, 2022
Follicular Lymphoma Trial in Australia (Opdivo)
Active, not recruiting
- Follicular Lymphoma
-
Ballarat, Victoria, Australia
- +4 more
Jan 30, 2023
Metastatic Colorectal Cancer Trial in Cairo (FOLFOXIRI Protocol)
Completed
- Metastatic Colorectal Cancer
- FOLFOXIRI Protocol
-
Cairo, El Manial, EgyptKasr El AiniH
Mar 30, 2022
Breast Cancer Stage IV, Oligometastatic Disease Trial (SABR)
Recruiting
- Breast Cancer Stage IV
- Oligometastatic Disease
- SABR
-
Gothenburg, Västra Götalandsregionen, SwedenSahlgrenska University Hospital
Oct 18, 2022
Education Trial in Malatya (Experimental: 1st Experimental Group, Experimental: 2nd Experimental Group)
Not yet recruiting
- Education
- Experimental: 1st Experimental Group
- Experimental: 2nd Experimental Group
-
Malatya, TurkeyTurgut Ozal Medical Center
Nov 16, 2023
Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)
Not yet recruiting
- Hodgkin Lymphoma
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Sep 19, 2023
FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer
Completed
- FIGO Stage III and IV Ovarian Cancer
- +2 more
- ALT-803 Subcutaneous
- ALT-803 Intraperitoneal
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Oct 5, 2022
Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- odetiglucan
- CDX-1140
- (no location specified)
Jul 29, 2022
Metastatic Colorectal Cancer Trial in Mecca (Panitumumab)
Recruiting
- Metastatic Colorectal Cancer
-
Mecca, Makkah Western, Saudi ArabiaKing Abdullah Medical City, Holy Capital
Apr 5, 2022
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Recruiting
- Promyelocytic Leukemia, Adult Acute
- Evaluation of first line treatment with ATO/ATRA outcome
-
Caba, Argentina
- +1 more
Nov 9, 2021
Palbociclib in Combination With an Aromatase Inhibitor
Recruiting
- Metastatic Breast Cancer
- Palbociclib + an aromatase inhibitor
- Aromatase inhibitor
-
New York, New York10017
May 2, 2022
Incidental Gallbladder Carcinoma-Permanent Platform Including
Recruiting
- Biliary Tract Cancer
- Neoadjuvant, Adjuvant and 1st Line
-
Frankfurt, GermanyKrankenhaus Nordwest GmbH
Aug 3, 2022
Metastatic Colorectal Cancer Trial in Munich (Bevacizumab, Irinotecan, Folinic acid)
Active, not recruiting
- Metastatic Colorectal Cancer
- Bevacizumab
- +5 more
-
Munich, GermanyKlinikum der Universitaet Muenchen
Dec 2, 2021
Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)
Active, not recruiting
- Locally Advanced or Metastatic Renal Cell Carcinoma
-
Salzburg, Austria
- +39 more
Jan 18, 2023
Nsclc Trial in Lille (procedure, drug, biological)
Terminated
- Nsclc
- Clinical exam
- +5 more
-
Lille, France
- +1 more
Oct 14, 2021